Vyome Holdings, Inc. (HIND) Stock Analysis & Investment Frameworks
Vyome Holdings, Inc. (HIND) stock analysis on Invetso. Review Vyome Holdings, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Vyome Holdings, Inc. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Vyome Holdings, Inc. Key Financial Metrics
- Market Cap: $13.12M
- Revenue: $319714.00
- ROE: -254.62%
- ROIC: -57.53%
- Dividend Yield: N/A
About Vyome Holdings, Inc.
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
Vyome Holdings, Inc. Investment Frameworks
Invetso analyzes Vyome Holdings, Inc. (HIND) across the following frameworks:
- Vyome Holdings, Inc. 10Y Growth Potential
- Vyome Holdings, Inc. Scenario Analysis
- Vyome Holdings, Inc. Risks & Opportunities
- Vyome Holdings, Inc. Economic Moat
- Vyome Holdings, Inc. Business Model
- Vyome Holdings, Inc. Management
- Vyome Holdings, Inc. SWOT Analysis
- Vyome Holdings, Inc. Porter's 5 Forces
- Vyome Holdings, Inc. PESTLE Analysis
- Vyome Holdings, Inc. ESG Analysis